Respiratory Pathogen Panel

Timely Testing With a Panel for Respiratory Pathogens

Respiratory testing must be timely because of severe respiratory illnesses. Madison Core Laboratories’ PCR testing identifies many respiratory pathogens, including COVID-19.

Contact Us

Why a Respiratory Pathogen Panel Is Needed

The COVID-19 pandemic has brought a lot of attention to the danger of respiratory infections. COVID alone accounted for almost 351,000 deaths in 2020. That same year, influenza and related pneumonia accounted for over 53,000 deaths, and other respiratory diseases like respiratory syncytial virus (RSV) caused even more deaths.

Respiratory infections can become serious very quickly, so respiratory testing for pathogens must be done with maximum accuracy and efficiency. Madison Core Labs’ PCR Respiratory Pathogen Panel answers these needs.

This comprehensive panel of respiratory pathogen tests can distinguish between benign infections and those that can be life-threatening. Compared to traditional culture testing, it is faster and more sensitive. And MCL makes testing reports easy to interpret, with a focus on actionable clinical data.

Respiratory Pathogen Panel Info Sheet

What Can the MCL Respiratory Pathogen Panel Do?

The PCR Respiratory Pathogen Testing Panel can identify several viral and bacterial pathogens, including:

  • Bordatella pertussis
  • Haemophilus influenzae 
  • Klebsiella pneumoniae
  • Legionells pneumophila
  • Moraxella catarrhalis
  • Micoplasma pneumoniae
  • Pseudomonas aeruginosa
  • Staphylococcus aureus
  • Streptococcus agalactiae
  • Streptococcus dysgalactia
  • Streptococcus pnumoniae
  • Streptococcus pyogenes
  • Human respiratory synciytial virus (RSV) species
  • Influenza A
  • Influenza B
  • SARS-CoV-2 (COVID-19) Molecular PCR Testing

By quickly identifying the cause of a respiratory infection, we help medical teams initiate treatment faster. Moreover, by identifying viral pathogens, we promote better antibiotic stewardship by indicating cases where they would not be effective.

PCR respiratory pathogen testing has come into the spotlight with the COVID-19 pandemic. It will continue to be a critical tool in distinguishing COVID from other infections and in helping sick patients get appropriate treatment as soon as possible.

Competitive Advantage

Rapid turn-around time provides actionable intelligence to providers with easy-to-interpret reports

Cost-effective solution as compared to other molecular labs that run large costly panels with little clinical evidence.

Clinical Indications

  1. Confirm the diagnosis of an infectious disease caused by respiratory infections, including COVID-19
  2. Help in the differential diagnosis of a pathogen 
  3. Assist in the evaluation of the prognosis of a respiratory tract infection 
  4. Monitor treatment outcome in a respiratory tract infection

Respiratory Pathogen Panel Info Sheet

Viral and Bacterial Organisms and Antibiotic Resistance Tests

  • Bordatella pertussis
  • Haemophilus influenzae
  • Klebsiella pneumoniae
  • Legionells pneumophila
  • Moraxella catarrhalis
  • Micoplasma pneumoniae
  • Pseudomonas aeruginosa
  • Staphylococcus aureus
  • Streptococcus agalactiae
  • Streptococcus dysgalactia
  • Streptococcus pnumoniae
  • Streptococcus pyogenes
  • Human respiratory synciytial virus (RSV) species
  • Influenza A
  • Influenza B
  • SARS-CoV-2 (COVID-19) Molecular PCR Testing
  • aaaC4 
  • ACC 
  • aphaA6 
  • Carbapenem Resistance-VIM, (blaVIM-2) 
  • ErmB 
  • mefA 
  • mecA 
  • GES 
  • Oxa_1 
  • Quinolone and Fluoroquniolone Resistance – QNRA (qnra2) 
  • Tetreacycline (tetM) 
  • VanAB (VanA2, VanB) 
  • Van C1